DEFINITIVE PROXY STATEMENT FOR ACADIA PHARMACEUTICALS INC.

Company

ACADIA PHARMACEUTICALS INC

Filed

April 24, 2006

Period of Report

June 13, 2006

Accession Number

0001193125-06-085908

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →